Business NewsPR NewsWire • New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

BALTIMORE, Oct. 26, 2020 /PRNewswire/ -- Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led...

View More : https://www.prnewswire.com:443/news-releases/new-landmark-study-at-um-school-of-medicine-finds-aspirin-use-reduces-risk-...
Releted News by prnewswire
Academy Sports + Outdoors Announces Offering of Senior Secured Notes
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Create Artistic Images with AKVIS ArtSuite 18.0: Now with Text!
GlobalSign and Infineon Present Webcast on Securing Device Identities in Public Key Infrastructure with Trusted Platform Modules